Live Breaking News & Updates on Achieved Over One Million

BASINGSTOKE, England and PHILADELPHIA, April 23 /PRNewswire/ - Within the First Eight Months Since its Introduction in the United States, VYVANSE has Achieved Over One Million Prescriptions - In a Clinical Study With Adults, VYVANSE was Shown to Significantly Improve the Symptoms of ADHD (Inattention, Hyperactivity and Impulsivity)(1) ....

United States , Johns Hopkins University , Lisdexamfetamine Dimesylate , Matthew Emmens , Davidw Goodman , Shire Plc , Us Department Of Health , Adult Attention Deficit Disorder Center , Johns Hopkins University School Of Medicine , National Comorbidity Survey Replication , American Psychiatric Association , Psychometric Properties , Exchange Commission , Shire Pharmaceuticals Inc , Drug Administration , National Prescription Audit , Child Health , American Academy Of Child , Us Centers For Disease , First Eight Months Since , Achieved Over One Million , Clinical Study With Adults , Significantly Improve , Attention Deficit Hyperactivity Disorder , Chief Executive Officer , Johns Hopkins University School ,